CAS: 1337532-51-0
6-Amino-7-bromo-9-methyl-7-deazapurine, 97%
CAS:1337532-51-0
It is used in the preparation of indoline derivatives as PERK inhibitors. This Thermo Scientific …
Formula:
C7H7BrN4
Purity:
97%
Molecular weight:
227.06
Ref: 02-H59897
1g | 357.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS:1337532-51-0
Formula:
C7H7BrN4
Purity:
97%
Color and Shape:
Solid
Molecular weight:
227.0613
Ref: IN-DA003MJU
1g | 124.00 € | ||
5g | 260.00 € | ||
25g | To inquire | ||
100mg | 63.00 € | ||
250mg | 77.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
5-BROMO-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
CAS:1337532-51-0
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
227.06500244140625
Ref: 10-F304471
1g | 95.00 € | ||
5g | 264.00 € | ||
10g | 496.00 € | ||
25g | 1,138.00 € | ||
100mg | 43.00 € | ||
250mg | 53.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS:1337532-51-0
Formula:
C7H7BrN4
Purity:
95%
Color and Shape:
pale yellow solid
Molecular weight:
227.06g/mol
Ref: 54-OR310814
1g | 109.00 € | ||
5g | 300.00 € | ||
25g | 1,202.00 € | ||
100mg | 53.00 € | ||
250mg | 56.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Controlled ProductCAS:1337532-51-0
Applications Used in the preparation of indoline derivatives as PERK inhibitors.
Formula:
C7H7BrN4
Color and Shape:
Neat
Molecular weight:
227.06
Ref: TR-B685530
5g | 747.00 € | ||
100mg | 94.00 € | ||
500mg | 168.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
6-Amino-7-bromo-9-methyl-7-deazapurine
CAS:1337532-51-0
Please enquire for more information about 6-Amino-7-bromo-9-methyl-7-deazapurine including the price, delivery time and more detailed …
Formula:
C7H7BrN4
Purity:
Min. 95%
Molecular weight:
227.06 g/mol
Ref: 3D-MDC53251
1g | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025